Literature DB >> 15706608

Broadly distributed nucleophilic reactivity of proteins coordinated with specific ligand binding activity.

Yasuhiro Nishiyama1, Yukie Mitsuda, Hiroaki Taguchi, Stephanie Planque, Mariko Hara, Sangeeta Karle, Carl V Hanson, Taizo Uda, Sudhir Paul.   

Abstract

Covalent nucleophile-electrophile interactions have been established to be important for recognition of substrates by several enzymes. Here, we employed an electrophilic amidino phosphonate ester (EP1) to study the nucleophilic reactivity of the following proteins: albumin, soluble epidermal growth factor receptor (sEGFR), soluble CD4 (sCD4), calmodulin, casein, alpha-lactalbumin, ovalbumin, soybean trypsin inhibitor and HIV-1 gp120. Except for soybean trypsin inhibitor and alpha-lactalbumin, these proteins formed adducts with EP1 that were not dissociated by denaturing treatments. Despite their negligible proteolytic activity, gp120, sEGFR and albumin reacted irreversibly with EP1 at rates comparable to the serine protease trypsin. The neutral counterpart of EP1 reacted marginally with the proteins, indicating the requirement for a positive charge close to the electrophilic group. Prior heating resulted in altered rates of formation of the EP1-protein adducts accompanied by discrete changes in the fluorescence emission spectra of the proteins, suggesting that the three-dimensional protein structure governs the nucleophilic reactivity. sCD4 and vasoactive intestinal peptide (VIP) containing phosphonate groups (EP3 and EP4, respectively) reacted with their cognate high-affinity binding proteins gp120 and calmodulin, respectively, at rates exceeding the corresponding reactions with EP1. Reduced formation of EP3-gp120 adducts and EP4-calmodulin adducts in the presence of sCD4 and VIP devoid of the phosphonate groups was evident, suggesting that the nucleophilic reactivity is expressed in coordination with non-covalent recognition of peptide determinants. These observations suggest the potential of EPs for specific and covalent targeting of proteins, and raise the possibility of nucleophile-electrophile pairing as a novel mechanism stabilizing protein-protein complexes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15706608     DOI: 10.1002/jmr.734

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  10 in total

1.  Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.

Authors:  Eric L Brown; Yasuhiro Nishiyama; Jesse W Dunkle; Shreya Aggarwal; Stephanie Planque; Kenji Watanabe; Keri Csencsits-Smith; M Gabriela Bowden; Sheldon L Kaplan; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

2.  Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold.

Authors:  Sotirios Koutsopoulos; Larry D Unsworth; Yusuke Nagai; Shuguang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

3.  Constant domain-regulated antibody catalysis.

Authors:  Gopal Sapparapu; Stephanie Planque; Yukie Mitsuda; Gary McLean; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

Review 4.  Back to the future: covalent epitope-based HIV vaccine development.

Authors:  Sudhir Paul; Stephanie Planque; Yasuhiro Nishiyama; Miguel Escobar; Carl Hanson
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

5.  Covalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog.

Authors:  Stephanie Planque; Miguel A Escobar; Keri C Smith; Hiroaki Taguchi; Yasuhiro Nishiyama; Elizabeth Donnachie; Kathleen P Pratt; Sudhir Paul
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

6.  Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds.

Authors:  Hiroaki Taguchi; Stephanie Planque; Gopal Sapparapu; Stephane Boivin; Mariko Hara; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2008-10-30       Impact factor: 5.157

7.  Metal-dependent amyloid β-degrading catalytic antibody construct.

Authors:  Yasuhiro Nishiyama; Hiroaki Taguchi; Mariko Hara; Stephanie A Planque; Yukie Mitsuda; Sudhir Paul
Journal:  J Biotechnol       Date:  2014-04-01       Impact factor: 3.307

8.  Toward effective HIV vaccination: induction of binary epitope reactive antibodies with broad HIV neutralizing activity.

Authors:  Yasuhiro Nishiyama; Stephanie Planque; Yukie Mitsuda; Giovanni Nitti; Hiroaki Taguchi; Lei Jin; Jindrich Symersky; Stephane Boivin; Marcin Sienczyk; Maria Salas; Carl V Hanson; Sudhir Paul
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

9.  CD4 binding determinant mimicry for HIV vaccine design.

Authors:  Yasuhiro Nishiyama; Stephanie Planque; Carl V Hanson; Richard J Massey; Sudhir Paul
Journal:  Front Immunol       Date:  2012-12-17       Impact factor: 7.561

10.  Protein modification by adenine propenal.

Authors:  Sarah C Shuck; Orrette R Wauchope; Kristie L Rose; Philip J Kingsley; Carol A Rouzer; Steven M Shell; Norie Sugitani; Walter J Chazin; Irene Zagol-Ikapitte; Olivier Boutaud; John A Oates; James J Galligan; William N Beavers; Lawrence J Marnett
Journal:  Chem Res Toxicol       Date:  2014-09-24       Impact factor: 3.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.